¡°	ertapenem salt	4.043526016036767
	minimize dimerization	3.3514131845782673
	Almarsson	3.242528759935922
	dimerization result	3.236345566301371
	carbon dioxide adduct	2.235765580758718
	final adduct	2.157788411173264
	increase hydrolysis	1.6346683982006305
	carbon dioxide source	1.5693525766672833
	carbon dioxide solution	1.1814591382891015
	standard lyophilization technique	1.0171387909887695
	specific lyophilization condition	1.0132906250926559
	expert testimony	1.0108131771820328
	Ertapenem	0.8117976363970386
	r6	0.8117976363970386
	lithium	0.8117976363970386
	cesium	0.8117976363970386
	rubidium	0.8117976363970386
	barium	0.8117976363970386
	Zeneca	0.8117976363970386
	almarsson	0.8117976363970386
	degradation pathway	0.7792555079756455
	lactam nitrogen	0.676344038523287
	pyrrolidine nitrogen	0.676344038523287
	unstable pH level	0.5629878388963602
	Invanz (r) product	0.5583722581095226
	r5	0.46826634061184297
	formula Ia	0.4175546033350979
	two degradation reaction	0.4040298524589228
	sodium hydroxide	0.3392815763033051
	hydrate	0.32642454957607664
	R4	0.32642454957607664
	C.	0.317452727467124
	objective evidence	0.2907615771752814
	mole ratio	0.2803359283466763
	preferred pH range	0.262587661365258
	alkali metal alkali earth metal	0.2607012982248957
	calcium	0.24736928917390266
	potassium	0.19670506214248276
	moisture content	0.1743289814558837
	creativity	0.1614489327431419
	No. CV	0.16137157610212022
	recipe	0.15608878020394765
	low temperature	0.1491795256223378
	copying	0.14811840481385427
¡°	antibiotic compound	0.14245536046591128
	magnesium	0.13553473500827615
	routine experimentation	0.12091231822479531
	red circle	0.11164565674569955
	temperature range	0.10123696594620178
	fear	0.10013134994049938
	Golden Blount	0.09219531541236427
	blue square	0.09132057605081752
	Decision	0.09049813644467145
	Apple Inc.	0.08752572241707642
	obvious implementation	0.07715954927542694
	Century Steps Inc.	0.0710681858014197
	reaction vessel	0.06568549478711032
	stable formulation	0.06057475203502422
	Delaware	0.05292861228005358
	routine way	0.04299040375842836
	five alternative formulation	0.032060738160626684
	nonobviousness	0.031584456808538844
	strong prima facie case	0.02415766611487385
	final formulation product	0.022992208265219333
	pharmaceutically acceptable salt	0.019983689294983842
	conventional manufacturing step	0.01989053181120389
	approval	0.017178941675780917
	manufacturing process	0.01630273311117829
	abbreviate drug application	0.015399671598058875
	ANDA	0.014139085162496089
	block effect	0.013514541524054161
	exclusive licensee	0.012645411285831671
	commercial success	0.012641951099093569
	secondary consideration	0.011640788882474757
	skilled chemist	0.010960787044244935
	Lourie	0.010297753795505349
	entity	0.008988050739562927
	principal component	0.00553449733829332
	Appellant Br	0.004985462303949944
	generic version	0.004895205742253586
	strong showing	0.0046236495072169495
	three broad general processing step	0.004558161668486569
	heavy one	0.004417059306594592
	definite firm conviction	0.004377386965840143
	active ingredient	0.004188570341943164
	commercial manufacture	0.003483116374724203
	miss limitation	0.003314912663797399
	skilled artisan	0.0033082322732571035
	bench trial	0.003297115814540265
	narrow range	0.003126911587162877
	Obviousness	0.0022296275340734114
	common sense	0.002019311523107701
	inventor extensive research effort	0.0019756125770491353
	none	0.0019112520041276342
	discovery	0.00129857504870337
	nothing	0.0010891805204313505
	dependent narrow limitation	0.000960178423057296
	May	0.0009099785889497712
	owner	0.0008623914670063434
	three step	0.0006730698898254715
	sale	0.0005272215765710257
	effective amount	0.00044417306580715504
	burden	0.00035184402974097875
	accuse process	0.00017830093325022043
	response	0.00010365519170089994
	underlie factual finding	9.327669731090931e-05
	background	7.789104389097524e-05
	knowledge	7.777554910331163e-05
	ordinary skill	7.042694240413022e-05
	substantial record evidence	5.729686055292712e-05
	original patentee	4.9437266524554245e-05
	clear error	4.050456468044066e-05
	holding	4.0033220979663456e-05
	jurisdiction	3.303374841304534e-05
	invalidity	3.094754309972187e-05
	method	2.897858191475453e-05
	law de novo	2.7264572859837595e-05
	district court factual finding	1.6776072271788706e-05
	decision	1.4977366577415132e-05
	order	1.2843872545468362e-05
	Claim	1.2428258269521485e-05
	court finding	6.5484169131619244e-06
	time	4.069760479775802e-06
	Idaho	3.0867178390329738e-06
	support evidence	1.8703161831513113e-06
	district court conclusion	1.1045280892120857e-06
	assert	8.490818653266541e-07
	prior art reference	4.009690265545686e-07
	base	1.6074052347596522e-07
	infringement action	5.937027065493784e-08
	invention	1.355477746548551e-08
	District	0.0
	Court	0.0
	Appeals	0.0
	Fed	0.0
